Heart Disease
Heart Disease Ongoing 2019

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk.

Trial overview

Disease
Structural Heart Disease
Topic
PORTICO-NG
Eligibility criteria

To be considered for the study you must meet the following criteria: 

  • 18 years of age or older 
  • Have a Society of Thoracic Surgeons (STS) score of ≥7% OR documented heart team agreement of high or extreme risk for surgical aortic valve replacement due to frailty or co-morbidities not captured by the STS score. 
  • Have symptomatic, severe aortic stenosis as demonstrated by NYHA Functional Classification of II, III or IV 
Study details

Your participation in this study would be for approximately12 months.   

You will need to undergo a minimally invasive surgical procedure to have the valve inserted and stay in hospital overnight. You will then be seen in the clinic at 30 days and 12 months post-procedure. During these visits you will be asked about your healthmedications, have a physical examination, 6-minute walk test, blood test, an ultrasound of your heart and ECG performed. 

Sign up to this clinical trial here.

Doctors

Prof. Stephen Worthley

MBBS, PhD, FRACP, FACC, FCSANZ, FRCP

Interventional Cardiologist

St Leonards (Cardiology)

Dr Joseph Montarello

MBBS, FRACP, FCSANZ

Interventional Cardiologist

Works at 6 centres.

Dr Anthony Camuglia

MBBS (Monash, Hons1), MHA (Monash), FRACP, FCSANZ

Interventional Cardiologist

Works at 2 centres.

Dr Sam Hayman

BSc, MSc, MBBS (Hons), FRACP

Interventional Cardiologist

Works at 2 centres.

Location